Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.

about

Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.

Item

http://www.wikidata.org/entity/Q48103728

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Plasma microRNA-based signatur ...... age II and III gastric cancer.

@en

Plasma microRNA-based signatur ...... age II and III gastric cancer.

@nl

type

Item

label

Plasma microRNA-based signatur ...... age II and III gastric cancer.

@en

Plasma microRNA-based signatur ...... age II and III gastric cancer.

@nl

prefLabel

Plasma microRNA-based signatur ...... age II and III gastric cancer.

@en

Plasma microRNA-based signatur ...... age II and III gastric cancer.

@nl

P1476

Plasma microRNA-based signatur ...... age II and III gastric cancer.

@en

P2093

Chenchen Wang

http://www.w3.org/2001/XMLSchema#string

Congqi Dai

http://www.w3.org/2001/XMLSchema#string

Fengjuan Lin

http://www.w3.org/2001/XMLSchema#string

Guoyou Qin

http://www.w3.org/2001/XMLSchema#string

Jin Li

http://www.w3.org/2001/XMLSchema#string

Jinjia Chang

http://www.w3.org/2001/XMLSchema#string

Menghong Sun

http://www.w3.org/2001/XMLSchema#string

Ruixuan Geng

http://www.w3.org/2001/XMLSchema#string

Weihua Jia

http://www.w3.org/2001/XMLSchema#string

Wenbo Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

A microRNA expression signature of human solid tumors defines cancer gene targets

MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN

Circulating microRNAs as stable blood-based markers for cancer detection.

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

Biogenesis of small RNAs in animals

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer.

MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis.

P304

2093-2102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.30895

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

141

http://www.w3.org/2001/XMLSchema#string

P50

Jiafu Ji

Xinyang Liu

P577

2017-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28722210

http://www.w3.org/2001/XMLSchema#string

P921

microRNA